| ₹ crore | Q4 FY26 | Q4 FY25 | Change |
|---|---|---|---|
| EBITDA | 366 | 263 | +39.4% |
| Profit before tax | 341 | 206 | +65.5% |
| Net profit | 345 | 206 | +67.5% |
| EPS | ₹1.87 | ₹1.13 | +65.5% |
L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 |
|---|
| 13,413 | — | — | |
| 250 | 250 | 250 | |
| 13,663 | — | — | |
| 125 | 125 | 71.1 | |
| 125 | 125 | 71.1 | |
| 131 | 131 | 214 | |
| ₹0.71 | ₹0.71 | ₹1.16 | |
| — | −38.8% | — | |
| — | 905 | 1,654 | |
| — | −48.6 | −41.4 | |
| 856 | 856 | 1,613 | |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|
| Market Capitalization | — | — | 13,413.2 | |
| + Total Debt | 250.0 | 250.0 | 250.0 | |
| Enterprise Value | — | — | 13,663.2 | |
| EBITDA | 71.1 | 125.5 | 125.5 | |
| EBIT | 71.1 | 125.5 | 125.5 | |
| Net Income | 213.5 | 130.8 | 130.8 | |
| EPS, Adj (current shares) | 1.16 | 0.71 | 0.71 | |
| Growth %, YoY | — | -38.8 | — | |
| Cash from Operations | 1,654.2 | 904.9 | — | |
| Capital Expenditures | -41.4 | -48.6 | — | |
| Free Cash Flow | 1,612.7 | 856.2 | 856.2 | |
Figures from the company's filings with NSE
In FY26 its consolidated net profit was ₹131 crore. Promoters held 55.29% of the shares on 30 September 2026.
Niva Bupa Health Insurance's debt-to-equity ratio was 0.07 on 31 March 2026: borrowings of ₹250 crore against total equity of ₹3,807 crore. A year earlier, on 31 March 2025, it was 0.07.
Niva Bupa Health Insurance's net worth — shareholders' equity in its consolidated balance sheet — was ₹3,807 crore on 31 March 2026, up 0.8% from ₹3,777 crore a year earlier.
Niva Bupa Health Insurance's book value per share was ₹20.63 on 31 March 2026: shareholders' equity of ₹3,807 crore divided by the 184.56 crore shares in issue, down 0.4% from ₹20.71 a year earlier.
In FY26, Niva Bupa Health Insurance's return on equity (ROE) was 3.5%. ROE is net profit divided by average shareholders' equity (the start and end of the year).
Niva Bupa Health Insurance's basic earnings per share (EPS) were ₹0.71 in FY26, against ₹1.22 in FY25. Over the last four quarters (Q1 FY26 to Q4 FY26) they add up to ₹0.71.
In FY26 (April 2025–March 2026), Niva Bupa Health Insurance's consolidated net profit was ₹131 crore, down 38.8% from ₹214 crore in FY25.
Promoters held 55.29% of Niva Bupa Health Insurance on 30 September 2026, down 0.01 percentage points from 55.30% the previous quarter and down 0.12 percentage points from 55.41% a year earlier, according to the shareholding pattern filed with NSE.
Niva Bupa Health Insurance's latest results are for Q4 FY26 (January–March 2026), filed on 8 May 2026: consolidated net profit ₹345 crore, up 67.5% from ₹206 crore in Q4 FY25.
On FY26 consolidated figures, against Star Health and Allied Insurance, ICICI Lombard and The New India Assurance: Niva Bupa Health Insurance's return on equity of 3.5% is the lowest of the four (Star Health and Allied Insurance 7.6%, ICICI Lombard 17.8%, The New India Assurance 5.7%; peer average 10.4%).
On 30 September 2026, Niva Bupa Health Insurance's shares were held by promoters 55.29%, foreign portfolio investors (FII/FPI) 12.95%, domestic institutions (DII) 15.89% (including mutual funds at 9.19%) and retail and other non-institutional investors 15.87%. Over the year, FII holding was up 2.23 percentage points from 10.72% and DII holding was up 0.58 percentage points from 15.31%.
In FY26, Niva Bupa Health Insurance earned net profit of ₹131 crore, against ₹557 crore for Star Health and Allied Insurance.
From Niva Bupa Health Insurance's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.